4/A
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-046265
Options or other derivatives
- Chief Scientific Officer acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Biller Scott Chief Scientific Officer | 2018-05-07 | Option exercise · Stock option (right to buy) | −3,000 | 22,154 | D: show line 1 in the form |
Loading xslF345X03/doc4a.xml…